Get started
Author

Ravi Kumar Rajan

Observed name: Rajan, Ravi Kumar
ORCID: 0000-0001-6064-7576
Observed ORCID: 0000-0001-6064-7576
OpenAlex ID: A5045536013
Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism
2016 · Ravi Kumar Rajan, Siva Selva Kumar M., et al. · Pharmaceutical Biology · 174
Crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer
2020 · H.A. Arjun, Ravi Kumar Rajan, et al. · Chemical Data Collections · 52
Design, Synthesis, and Biological Evaluation of 2‐(2‐Bromo‐3‐nitrophenyl)‐5‐phenyl‐1,3,4‐oxadiazole Derivatives as Possible Anti‐Breast Cancer Agents
2020 · Arjun H. Ananth, Natarajan Manikandan, et al. · Chemistry & Biodiversity · 33
A comprehensive review on adaptive plasticity and recovery mechanisms post‐acquired brain injury
2025 · Ravi Kumar Rajan · Neuroprotection/Neuroprotection (Chichester, England. Print) · 24
PDF
Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay
2020 · Ravi Kumar Rajan, M. Ramanathan · Journal of Computer-Aided Molecular Design · 13
Network pharmacology and in-silico approaches to elucidate the antimicrobial mechanism of Aesculus assamica Griff. for the treatment of skin infection
2025 · Ravi Kumar Rajan, Farak Ali, et al. · In Silico Research in Biomedicine · 10
Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl‐2/Cyt‐c/caspase‐dependent pathways in the oxygen–glucose deprived SHSY‐5Y cell lines: In silico and in vitro study
2024 · Ravi Kumar Rajan, M. Ramanathan · Chemical Biology & Drug Design · 8
Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection
2023 · Ravi Kumar Rajan, Ram Pravin Kumar, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 8
Piceatannol: a multifaceted polyphenol—from pharmacological actions to formulation development and clinical trials
2025 · Ravi Kumar Rajan, Bedanta Bhattacharjee, et al. · Oriental Pharmacy and Experimental Medicine · 7
In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)
2022 · Umaa Kuppuswamy, Ravi Kumar Rajan, et al. · Future Journal of Pharmaceutical Sciences · 5
PDF
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?
2025 · Ravi Kumar Rajan · Pigment Cell & Melanoma Research · 4
PDF
C–Glucosyl Xanthone derivative Mangiferin downregulates the JNK3 mediated caspase activation in Almal induced neurotoxicity in differentiated SHSY-5Y neuroblastoma cells
2023 · Nafila PK, Ravi Kumar Rajan, et al. · Toxicology Mechanisms and Methods · 4
Predicting phase-I metabolism of piceatannol: an in silico study
2024 · Ravi Kumar Rajan, Maida Engels, et al. · In Silico Pharmacology · 3
PDF
“Leucine zipper proteins as emerging therapeutic regulators: structural dynamics, disease associations, and novel targeting strategies”
2025 · Anjali Kumari, Adiba Mussarrat, et al. · Cell Cycle · 2
PDF
Exploring the antidepressant potential of Drymaria cordata Willd. ex Schult - A comprehensive review
2025 · Rupam Kalita, Ravi Kumar Rajan, et al. · Journal of Ethnopharmacology · 2
A Miswired Ovarian Ecosystem: LIF/JAK/STAT3 Distortion in PCOS
2026 · Anisha Sharma, Shalini Singh, et al. · Reproductive Sciences · 1
A review of potential beneficial effects of herbal phytotherapy in mitigating drug-induced nephrotoxicity
2026 · Rahul Pradhan, Ananya Bhattacharjee, et al. · Clinical Phytoscience · 1
PDF
Design, synthesis, molecular docking, and crystal structure of benzohydrazide derivative as anti-cancer agents
2026 · H.A. Arjun, N. Manikandan, et al. · Results in Chemistry · 1
Emerging Roles of Exosomal miRNAs in Mediation of Kidney Stone Pathogenesis
2026 · Visetonu Victoria Vitsu, Chumchamo T. Humtsoe, et al. · MicroRNA
The Genus Oxalis: Ethnomedicinal Relevance, Phytochemical Diversity, Pharmacological Activities, and Toxicological Perspectives - A Comprehensive Review
2026 · Safal Sharma, Nihar Ranjan Bhuya, et al. · Journal of Natural Remedies
Understanding the OMA1-DELE1-HRI Axis and PINK1-parkin-mediated Mitophagy in Parkinson’s Disease
2026 · Shalini Singh, Anisha Sharma, et al. · CNS & Neurological Disorders - Drug Targets
Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of phytoconstituents identified from Oxalis triangularis by GC–MS and LC–MS analysis against colorectal cancer
2026 · Safal Sharma, Nihar Ranjan Bhuyan, et al. · In Silico Pharmacology
Evaluating the antidepressant and neuroprotective effect of Drymaria cordata (L.) Willd. Ex Schult against a CUMS-induced depression model: A comprehensive experimental and computational study
2026 · Rupam Kalita, Ravi Kumar Rajan, et al. · Journal of Ethnopharmacology
“EPAC1: Molecular architecture, physiological regulation, and therapeutic implications in diseases”
2026 · Adiba Mussarrat, Anjali Kumari, et al. · The International Journal of Biochemistry & Cell Biology
JAK/STAT Signaling: From Mechanisms to Emerging Therapeutics
2026 · Shalini Singh, Anjali Kumari, et al. · Current Signal Transduction Therapy
Works count: 38
Citation count: 352
H-index: 8
I10-index: 6
Year
Topic
Type